A thermostable mRNA vaccine against COVID-19

Cited by (670)

Items 301–400 of 670

1. A highly immunogenic live-attenuated vaccine candidate prevents SARS-CoV-2 infection and transmission in hamsters
   Xiaofeng Li, Zhen Cui, Hang Fan, Qi Chen, Lei Cao, Hongying Qiu, Nana Zhang, Yan‐Peng Xu, Rongrong Zhang, Chao Hui ZHOU et al. · 2022 · The Innovation
2. A tale of nucleic acid–ionizable lipid nanoparticles: Design and manufacturing technology and advancement
   Anindita De, Young Tag Ko · 2022 · Expert Opinion on Drug Delivery
3. EGR1 functions as a new host restriction factor for SARS-CoV-2 to inhibit virus replication through the E3 ubiquitin ligase MARCH8
   Ying-Hua Zhao, Li-Yan Sui, Ping Wu, Le-Tian Li, Li Liu, Bao-Hua Ma, Wen-Fang Wang, Hongmiao Chi, Ze-Dong Wang, Zhengkai Wei et al. · 2023 · Journal of Virology
4. Adjuvants for cancer mRNA vaccines in the era of nanotechnology: strategies, applications, and future directions
   Lei‐Ming Cao, Yi-Fu Yu, Zi‐Zhan Li, Nian‐Nian Zhong, Guang-Rui Wang, Yao Xiao, Bing Liu, Qiuji Wu, Chun Feng, Lin‐Lin Bu · 2024 · Journal of Nanobiotechnology
5. Biosecurity risks associated with vaccine platform technologies
   Jonas B. Sandbrink, Gregory D. Koblentz · 2021 · Vaccine
6. Potential SARS-CoV-2 vaccines: Concept, progress, and challenges
   Seyede Atefe Hosseini, Fatemeh Zahedipour, Hamed Mirzaei, Reza Kazemi Oskuee · 2021 · International Immunopharmacology
7. Meeting vaccine formulation challenges in an emergency setting: Towards the development of accessible vaccines
   Allegra Peletta, Céline Lemoine, Thomas Courant, Nicolas Collin, Gerrit Borchard · 2023 · Pharmacological Research
8. Vaccinia virus-based vaccines confer protective immunity against SARS-CoV-2 virus in Syrian hamsters
   Rakesh Kulkarni, Wen-Ching Chen, Ying Lee, Chi‐Fei Kao, Shiu-Lok Hu, Hsiu‐Hua Ma, Jia‐Tsrong Jan, Chun‐Che Liao, Jian‐Jong Liang, Hui‐Ying Ko et al. · 2021 · PLoS ONE
9. Protective Immune Responses Induced by an mRNA-LNP Vaccine Encoding prM-E Proteins against Japanese Encephalitis Virus Infection
   Tao Chen, Shuo Zhu, Ning Wei, Zikai Zhao, Junjun Niu, Youhui Si, Shengbo Cao, Jing Ye · 2022 · Viruses
10. Lipid‐based nucleic acid therapeutics with in vivo efficacy
    Md Abu Sufian, Marc Antoniu Ilies · 2022 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology
11. An updated review on pathogenic coronaviruses (CoVs) amid the emergence of SARS-CoV-2 variants: A look into the repercussions and possible solutions
    Ali Ahmed Rabaan, Maha Fahad Alenazy, Ahmad A. Alshehri, Mohammed Abdulrahman Alshahrani, Maha F. Al‐Subaie, Hayam Ali AlRasheed, Nawal Ahmed Mohamed Al Kaabi, Nanamika Thakur, Nabiha A. Bouafia, Mohammed Alissa et al. · 2023 · Journal of Infection and Public Health
12. Nanoemulsions and nanocapsules as carriers for the development of intranasal mRNA vaccines
    Mireya L. Borrajo, Gustavo Lou, Shubaash Anthiya, Philipp Lapuhs, David Moreira, Araceli Tobío, Marı́a Isabel Loza, Anxo Vidal, Marı́a José Alonso · 2024 · Drug Delivery and Translational Research
13. Advances of nanomaterials‐based strategies for fighting against COVID‐19
    Chunxi Zeng, Xucheng Hou, Margaret Bohmer, Yizhou Dong · 2021 · Open Research (University of Surrey)
14. Multifunctional Lipid Nanoparticles for Protein Kinase N3 shRNA Delivery and Prostate Cancer Therapy
    Ji Wang, Yanhao Zhang, Chao Liu, Wenhui Zha, Shuo Dong, Hanlei Xing, Xinsong Li · 2022 · Molecular Pharmaceutics
15. How far are the new wave of mRNA drugs from us? mRNA product current perspective and future development
    Qiongyu Duan, Tianyu Hu, Qiuxia Zhu, Xueying Jin, Feng Chi, Xiaodong Chen · 2022 · Frontiers in Immunology
16. Fullerene-based nanocomplex assists pulmonary delivery of siRNA for treating metastatic lung cancer
    Shuai Liu, Xiangyu Sun, Huan Lu, Daiqin Chen, Xue Li, Lei Li, Shenge Su, Zhongpu Zhao, Xinran Cao, Libing Liu et al. · 2023 · Nano Today
17. Efficient signal sequence of mRNA vaccines enhances the antigen expression to expand the immune protection against viral infection
    Yupei Zhang, Songhui Zhai, Hai Huang, Shugang Qin, Min Sun, Yuting Chen, Xing Lan, Guo-Hong Li, Zhiying Huang, D. Wang et al. · 2024 · Journal of Nanobiotechnology
18. Isolating Nanoparticles from Complex Biological Media by Immunoprecipitation
    Youcef Chakib Hacene, Alexis Loiseau, Vanessa Dos Passos Maio, Philippe Grenier, Élodie Boisselier, Nicolas Bertrand · 2021 · Nano Letters
19. Droplet Microfluidics for High-Resolution Virology
    Wenyang Jing, Hee‐Sun Han · 2022 · Analytical Chemistry
20. Impact of administration routes and dose frequency on the toxicology of SARS-CoV-2 mRNA vaccines in mice model
    Jae-Hun Ahn, Jisun Lee, Gahyun Roh, Na-Young Lee, Hee-Jin Bae, Euna Kwon, Kang Min Han, Ji-Eun Kim, Hyo‐Jung Park, Soyeon Yoo et al. · 2024 · Archives of Toxicology
21. Specific muscle targeted delivery of miR-130a loaded lipid nanoparticles: a novel approach to inhibit lipid accumulation in skeletal muscle and obesity
    Ying-Qian Wang, Zeqiang Ma, Le-Hua Jiang, N. Bojan, Yi-Wen Sha, Bo-Yu Huang, Lianxi Ming, Jun-Nan Shen, Wei-Jun Pang · 2025 · Journal of Nanobiotechnology
22. Isotope Labels Combined with Solution NMR Spectroscopy Make Visible the Invisible Conformations of Small-to-Large RNAs
    Theodore Kwaku Dayie, Lukasz T. Olenginski, Kehinde M. Taiwo · 2022 · Chemical Reviews
23. Virus-Like Particles Are Efficient Tools for Boosting mRNA-Induced Antibodies
    Anne‐Cathrine S. Vogt, Lukas Jörg, B. E. E. Martina, Pascal S. Krenger, Xinyue Chang, Andris Zeltiņš, Monique Vogel, Mona Omar Mohsen, Martin F. Bachmann · 2022 · Frontiers in Immunology
24. Unraveling the Multifaceted Roles of Extracellular Vesicles: Insights into Biology, Pharmacology, and Pharmaceutical Applications for Drug Delivery
    Ali Al-Jipouri, Àuria Eritja, Milica Božić · 2023 · International Journal of Molecular Sciences
25. Highly Sensitive, Multiparametric Thermal History Phosphor Based on An Eu(BTC) Architecture
    Maja Szymczak, Anna Mauri, Simona Galli · 2024 · Advanced Functional Materials
26. Rapid development of double-hit mRNA antibody cocktail against orthopoxviruses
    Hang Chi, Suo-Qun Zhao, Ru‐Yi Chen et al. · 2024 · Signal Transduction and Targeted Therapy
27. A pathogen-like antigen-based vaccine confers immune protection against SARS-CoV-2 in non-human primates
    Chang Ming Guo, Yanan Peng, Lin Lin, Xiaoyan Pan, Mengqi Fang, Yun Zhao, Keyan Bao, Runhan Li, Jian-Bao Han, Jiaorong Chen et al. · 2021 · Cell Reports Medicine
28. Unraveling Macrophage Polarization: Functions, Mechanisms, and “Double-Edged Sword” Roles in Host Antiviral Immune Responses
    Yao Meng, Meilin Li, Dingkun Peng, Yijing Wang, Su Li, Ding Zhang, Bo Kyung Yang, Hua‐Ji Qiu, Lian‐Feng Li · 2024 · International Journal of Molecular Sciences
29. Efforts towards a COVID ‐19 vaccine
    Harald Brüssow · 2020 · Environmental Microbiology
30. A mini DNA–RNA hybrid origami nanobrick
    Lifeng Zhou, Arun Richard Chandrasekaran, Mengwen Yan · 2021 · Nanoscale Advances
31. COVID-19 Vaccines: Where Did We Stand at the End of 2023?
    Kenneth H. Lundstrom · 2024 · Viruses
32. Advancing vaccine development: Evaluation of a mannose-modified lipid nanoparticle-based candidate for African swine fever p30 mRNA vaccine eliciting robust immune response in mice
    Lele Gong, Yuanyuan Zhang, Lele Wang, Xuyang Zhao, Lucai Wang, Xiangqi Qiu, Xilong Yang, Wenhui Zhu, Lijie Lv, Yunzhe Kang et al. · 2024 · International Journal of Biological Macromolecules
33. The race for a COVID-19 vaccine: where are we up to?
    Md Kamal Hossain, Majid Hassanzadeganroudsari, Jack Feehan, Vasso Apostolopoulos · 2021 · Expert Review of Vaccines
34. RNA cancer vaccines: developing mRNA nanovaccine with self-adjuvant property for cancer immunotherapy
    Hongxia Zhang, Xiaojun Xia · 2021 · Human Vaccines & Immunotherapeutics
35. SARS-CoV-2 virus: Vaccines in development
    Qing-Rui Huang, Jing-Hua Yan · 2021 · Fundamental Research
36. Detection, prevention and treatment of COVID‐19 and opportunities for nanobiotechnology
    Qing Bao, Tao Yang, Mingying Yang, Chuanbin Mao · 2022 · Open Research (University of Surrey)
37. Modeling a closed-loop vaccine supply chain with transshipments to minimize wastage and threats to the public: a system dynamics approach
    Esen Andiç-Mortan, Cigdem Gonul Kochan · 2023 · Journal of Humanitarian Logistics and Supply Chain Management
38. Development of an mRNA vaccine against a panel of heterologous H1N1 seasonal influenza viruses using a consensus hemagglutinin sequence
    Ning Ma, Zhi-Wu Xia, Zhegang Zhang, Xuanxuan Nian, Xue-Dan Li, Zheng Gong, Guomei Zhang, Le Yang, Rong Zhou, Jiayou Zhang et al. · 2023 · Emerging Microbes & Infections
39. Enhancing antitumor immunity and achieving tumor eradication with IL11RA mRNA immunotherapy
    Adeel ur Rehman, Zhihuai Wang, Qianshan Qin, X. X. Zhang, Aleena Akhtar, Hanyang Liu, Binli Mao, Naveed Khan, Liming Tang, Xiaosong Li · 2024 · International Immunopharmacology
40. An mpox quadrivalent mRNA vaccine protects mice from lethal vaccinia virus challenge
    Entao Li, Qizan Gong, Jiachen Zhang et al. · 2024 · Antiviral Research
41. Advances in Therapeutic L-Nucleosides and L-Nucleic Acids with Unusual Handedness
    Yuliya Dantsu, Ying Zhang, Wen Zhang · 2021 · Genes
42. Identification of a Potential mRNA‐based Vaccine Candidate against the SARS‐CoV‐2 Spike Glycoprotein: A Reverse Vaccinology Approach
    Olanrewaju Ayodeji Durojaye, Divine Mensah Sedzro, Mukhtar Oluwaseun Idris, Abeeb Abiodun Yekeen, Adeola Abraham Fadahunsi, Oluwaseun Suleiman Alakanse · 2022 · ChemistrySelect
43. Advances in Pathogenesis, Progression, Potential Targets and Targeted Therapeutic Strategies in SARS-CoV-2-Induced COVID-19
    Hong Zhou, Wei‐Jian Ni, Wei Huang, Zhen Wang, Ming Cai, Yan-Cai Sun · 2022 · Frontiers in Immunology
44. Emerging mRNA Technology for Liver Disease Therapy
    Ji Wang, Yile Fang, Zhiqiang Luo, Jinglin Wang, Yuanjin Zhao · 2024 · ACS Nano
45. Advancement in the development of mRNA ‐based vaccines for respiratory viruses
    Tays Troncoso‐Bravo, Mario A. Ramírez, Ricardo A. Loaiza, Carolina Román-Cárdenas, Georgios Papazisis, Daniel A. Garrido, Pablo A. González, Susan M. Bueno, Alexis M. Kalergis · 2024 · Immunology
46. Establishment of enterically transmitted hepatitis virus animal models using lipid nanoparticle-based full-length viral genome RNA delivery system
    Tianxu Liu, Jian Li, Xin Yin, Fengmin Lu, Hui John Zhao, Lin Wang, Cheng‐Feng Qin · 2024 · Gut
47. RNA vaccines: The dawn of a new age for tuberculosis?
    Junli Li, Dong Liu, Xiaochi Li, Jiazheng Wei, Weixin Du, Aihua Zhao, Miao Xu · 2025 · Human Vaccines & Immunotherapeutics
48. Recent advances in detection technologies for COVID-19
    Tingting Han, Hailin Cong, Youqing Shen, Bing Yu · 2021 · Talanta
49. Investigating the Efficacy of a Canine Rabies Vaccine Following Storage Outside of the Cold-Chain in a Passive Cooling Device
    Ahmed Lugelo, Katie Hampson, Anna Czupryna · 2021 · Frontiers in Veterinary Science
50. Immunological Mechanisms of Vaccine-Induced Protection against SARS-CoV-2 in Humans
    Keshav Goyal, Harsh Goel, Pritika Baranwal, Anisha Tewary, Aman Dixit, Avanish Kumar Pandey, Mercilena Benjamin, Pranay Tanwar, Abhijit Dey, Fahad Khan et al. · 2021 · Immuno
51. Delivery of Circular mRNA via Degradable Lipid Nanoparticles against SARS-CoV-2 Delta Variant
    Ke Huang, Na Li, Yingwen Li, Jiafeng Zhu, Qianyi Fan, Jiali Yang, Yinjia Gao, Yupin Liu, Qiangbo Hou, Shufeng Gao et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
52. RBD-displaying OMV nanovaccine boosts immunity against SARS-CoV-2
    Rang Feng, Ruo‐Yi Xue, Chang Liu, Guo-Cheng Li, Yan Deng, Zhe Jin, Jing-Yi Liu, Shanshan Zhang, Hao Cheng, Mingen Guo et al. · 2025 · Journal of Nanobiotechnology
53. Advances in mRNA vaccine therapy for breast cancer research
    Jiaying Li, Ruiyuan Jiang, Jia Wang, Xiaojia Wang · 2025 · Discover Oncology
54. Identifying and repurposing antiviral drugs against severe acute respiratory syndrome coronavirus 2 with in silico and in vitro approaches
    K. Watashi · 2020 · Biochemical and Biophysical Research Communications - BBRC
55. Revolutionizing viral disease vaccination: the promising clinical advancements of non-replicating mRNA vaccines
    Xiao Guo, Dongying Liu, Yukai Huang, Youcai Deng, Ying Wang, Jingrui Mao, Yuancheng Zhou, Yongai Xiong, Xinghong Gao · 2023 · Virology Journal
56. Nanoparticles Based on Natural Lipids Reveal Extent of Impacts of Designed Physical Characteristics on Biological Functions
    Niko Kimura, Yôko Tanaka, Yoko Yamanishi, Akiko Takahashi, Shinya Sakuma · 2024 · ACS Nano
57. The immunogenic potential of an optimized mRNA lipid nanoparticle formulation carrying sequences from virus and protozoan antigens
    Renata Streck Fernandes, Gabriela de Assis Burle-Caldas, Sarah Aparecida Rodrigues Sérgio, Ana Flávia Bráz, Nathália Pereira da Silva Leite, Milton C. A. Pereira, Juliana de Oliveira Silva, Natália Satchiko Hojo-Souza, Bianca de Oliveira, Ana Paula Fernandes et al. · 2025 · Journal of Nanobiotechnology
58. Deep sequence modelling for predicting COVID-19 mRNA vaccine degradation
    Talal S. Qaid, Hussein H. Maza'ar, Mohammed S. Alqahtani · 2021 · PeerJ Computer Science
59. Nanotechnology and COVID-19: quo vadis?
    João Lima Tavares, Iago Dillion Lima Cavalcanti, Nereide Stela Santos-Magalhães, Mariane Cajubá de Britto Lira Nogueira · 2022 · Journal of Nanoparticle Research
60. Modern Strategies of Drug Therapy: Multi-Target Drug Delivery, Bioimaging, Diagnostics
    Olga V. Fedorova, I.G. Ovchinnikova, G. L. Rusinov, Varvara Vladimirovna Avdeeva, А. P. Zhdanov, K.Yu. Zhizhin, Nikolay T. Kuznetsov, Lucia Ya. Zakharova, Darya A. Kuznetsova, Yuliya S. Razuvayeva et al. · 2025 · Russian Journal of General Chemistry
61. Biocompatible All-in-One Adhesive Needle-Free Cup Patch for Enhancing Transdermal Drug Delivery
    Moonjeong Bok, Zhi‐Jun Zhao, Soon Hyoung Hwang · 2021 · ACS Applied Materials & Interfaces
62. Bafilomycin A1 inhibits SARS-CoV-2 infection in a human lung xenograft mouse model
    Cuiling Zhang, Bingjie Wei, Zirui Liu, Wei Yao, Yiquan Li, Jing Lü, Chenchen Ge, Xiaoyang Yu, Dapeng Li, Yilong Zhu et al. · 2023 · Virology Journal
63. Rapid evaluation of heterologous chimeric RBD-dimer mRNA vaccine for currently-epidemic Omicron sub-variants as booster shot after inactivated vaccine
    Qian Chen, Pei Du, Yuxuan Han, Xuehui Ma, Rong Zhang, Xiaoyu Rong, Xu Zhao, Renyi Ma, Huiting Yang, Anqi Zheng et al. · 2023 · Biosafety and Health
64. Bivalent mRNA vaccines against three SARS-CoV-2 variants mediated by new ionizable lipid nanoparticles
    Ji Wang, Yanhao Zhang, Shuo Dong, Wenhui Zha, Chao Liu, Yang Wang, Yuhao Jiang, Hanlei Xing, Xinsong Li · 2023 · International Journal of Pharmaceutics
65. Supermolecular nanovehicles co-delivering TLR7/8-agonist and anti-CD47 siRNA for enhanced tumor immunotherapy
    Tongyi Shang, Xinying Yu, Yuan Gu et al. · 2023 · International Journal of Biological Macromolecules
66. An Ultrahydrating Polymer that Protects Protein Therapeutics and RNA‐Lipid Nanoparticles Against Freezing, Heat and Lyophilization Stress
    Anna Herrmann, Srinivas Abbina, Nuthan Vikas Bathula, Peyman Malek Mohammadi Nouri, Irina Chafeeva, Iren Constantinescu, Emaan Abbasi, Usama Abbasi, Matthew Drayton, Haiming Daniel Luo et al. · 2024 · Advanced Functional Materials
67. Golden Threads of Lipid Nanoparticles (LNPs) contributing to COVID-19 mRNA Vaccine: A Review
    Mahanthi Vasu, Pinaj Yadav, Yalakala Satyanarayana, Jahnvi Ahlawat, Sandeep Dulla, K Naresh Kumar · 2024 · BioNanoScience
68. Single pot organic solvent-free thermocycling technology for siRNA-ionizable LNPs: a proof-of-concept approach for alternative to microfluidics
    Anindita De, Young Tag Ko · 2022 · Drug Delivery
69. Self-replicating RNA nanoparticle vaccine elicits protective immune responses against SARS-CoV-2
    Guibin Lin, Huan Yan, Jing Sun, Jincun Zhao, Yuan Zhang · 2023 · Molecular Therapy — Nucleic Acids
70. Advances and perspectives in the development of vaccines against highly pathogenic bunyaviruses
    Tong Chen, Zhe Ding, Jiaming Lan · 2023 · Frontiers in Cellular and Infection Microbiology
71. Autoimmune response after SARS-CoV-2 infection and SARS-CoV-2 vaccines
    Altijana Hromić‐Jahjefendić, Kenneth H. Lundstrom, Muhamed Adilović, Alaa A. A. Aljabali, Murtaza M. Tambuwala, Ángel Serrano‐Aroca, Vladimir Nikolaevich Uversky · 2023 · Autoimmunity Reviews
72. An mRNA vaccine encoding the SARS-CoV-2 receptor-binding domain protects mice from various Omicron variants
    Ryuta Uraki, Masaki Imai, Mutsumi Ito, Seiya Yamayoshi, Maki Kiso, Nao Jounai, Kazuki Miyaji, Kiyoko Iwatsuki‐Horimoto, Fumihiko Takeshita, Yoshihiro Kawaoka · 2024 · npj Vaccines
73. Rapid identification of A29L antibodies based on mRNA immunization and high-throughput single B cell sequencing to detect Monkeypox virus
    Huisheng Sun, Yiqi Miao, Xingsheng Yang et al. · 2024 · Emerging Microbes & Infections
74. Harnessing biomaterials for therapeutic strategies against COVID-19
    Thibault Colombani, Zachary J. Rogers, Loek J. Eggermont, Sidi A. Bencherif · 2021 · Emergent Materials
75. A PEG-lipid-free COVID-19 mRNA vaccine triggers robust immune responses in mice
    Min Li, Yixuan Huang, Jiacai Wu, Sanpeng Li, Miao Mei, Haixia Chen, Ning Wang, Weigang Wu, Boping Zhou, Xu Tan et al. · 2022 · Materials Horizons
76. The first Chinese national standards for SARS-CoV-2 neutralizing antibody
    Lidong Guan, Yuanling Yu, Xiaohong Wu, Jianhui Nie, Jun Zhang, Zejun Wang, Na Li, Rui Shi, Hui John Zhao, Hongbo Chen et al. · 2021 · Vaccine
77. Structural characterization of mRNA lipid nanoparticles (LNPs) in the presence of mRNA-free LNPs
    Xiaoxia Chen, Yongfeng Ye, Mengrong Li, Taisen Zuo, Zhenhua Xie, Yubin Ke, He Cheng, Liang Hong, Zhuo Liu · 2025 · Journal of Controlled Release
78. Trends and perspectives in bio- and eco-friendly sustainable nanomaterial delivery systems through biological barriers
    Seongchan Kim, Taegon Oh, Hyojin Lee, Jwa‐Min Nam · 2022 · Materials Chemistry Frontiers
79. Nanotechnology-Based RNA Vaccines: Fundamentals, Advantages and Challenges
    Vitaly P. Pozharov, Tamara Minko · 2023 · Pharmaceutics
80. A rabies mRNA vaccine provides a rapid and long-term immune response in mice
    Jinrong Long, Changxiao Yu, Yiming Cao, Yiqi Miao, Huisheng Sun, Zhen Zhang, Jierui Mai, Xin Wang, Yingying Mao, Hongwei Li et al. · 2023 · Nano Today
81. Pathogenesis and virulence of coronavirus disease: Comparative pathology of animal models for COVID-19
    Natalie M. Kirk, Yu-Ying Liang, H. Ly · 2024 · Virulence
82. Immunogenicity of an AAV-based, room-temperature stable, single dose COVID-19 vaccine in mouse and non-human primates
    Nerea Zabaleta, Wenlong Dai, Urja Bhatt, Jessica A Chichester, Julio Sanmiguel, Reynette Estelien, Kristofer T Michalson, Cheikh Diop, Dawid Maciorowski, Wenbin Qi et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
83. Self‐Organization of Iron Sulfide Nanoparticles into Complex Multicompartment Supraparticles
    Emine Sumeyra Turali Emre, Ahmet Emrehan Emre, Drew A. Vecchio, Usha Kadiyala, J. Scott VanEpps, Nicholas A. Kotov · 2023 · Advanced Materials
84. Harnessing Biomaterials to Amplify Immunity in Aged Mice through T Memory Stem Cells
    Mohammad Mahdi Hasani‐Sadrabadi, Fatemeh Sadat Majedi, Jana Zárubová, Timothy J. Thauland, Vaithilingaraja Arumugaswami, Tzung K. Hsiai, Louis‐S. Bouchard, Manish J. Butte, Song Li · 2024 · ACS Nano
85. SARS-CoV-2 NSP6 reduces autophagosome size and affects viral replication via sigma-1 receptor
    Cuiling Zhang, Qiwei Jiang, Zirui Liu, Nan Li, Zhuo Hao, Gaojie Song, Dapeng Li, Minghua Chen, Lisen Lin, Yan Liu et al. · 2024 · Journal of Virology
86. Protective Immunity against Gamma and Zeta Variants after Inactivated SARS-CoV-2 Virus Immunization
    Marcílio Jorge Fumagalli, Luíza Antunes de Castro-Jorge, Thais Fernanda de Campos Fraga‐Silva, Patrick Orestes de Azevedo, Carlos Fabiano Capato, Bruna Amanda da Cruz Rattis, Natália Satchiko Hojo-Souza, Vitor Gonçalves Floriano, Júlia Teixeira de Castro, Simone Gusmão Ramos et al. · 2021 · Viruses
87. Advances in nanotechnology application in biosafety materials: A crucial response to COVID-19 pandemic
    Rasmi V. Morajkar, Akhil Sree Kumar, Rohan Keshav Kunkalekar, Amit Ashok Vernekar · 2022 · Biosafety and Health
88. COVID-19 mitigation: nanotechnological intervention, perspective, and future scope
    Arpita Adhikari, Dibyakanti Mandal, Dipak Kumar Rana, Jyotishka Nath, Aparajita Bose, Sonika Sonika, Jonathan Tersur Orasugh, Sriparna De, Dipankar Chattopadhyay · 2022 · Materials Advances
89. Construction and immunogenicity of an mRNA vaccine against chikungunya virus
    Jingjing Liu, Xishan Lu, Xingxing Li, Weijin Huang, Enyue Fang, Wenjuan Li, Xiaohui Liu, Minglei Liu, Jia Li, Ming Li et al. · 2023 · Frontiers in Immunology
90. Induction of liver-resident memory T cells and protection at liver-stage malaria by mRNA-containing lipid nanoparticles
    Sayuri Nakamae, Satoshi Miyagawa, Koki Ogawa, M. Kamiya, M. Taniguchi, A. Ono, M. Kawaguchi, A. A. Teklemichael, Jiun-Yu Jian, Tamasa Araki et al. · 2023 · Frontiers in Immunology
91. COVID-19 mRNA Vaccine Degradation Prediction using Regularized LSTM Model
    Sheikh Asif Imran, Md. Tariqul Islam, Celia Shahnaz · 2020 · IEEE International Women in Engineering (WIE) Conference on Electrical and Computer Engineering (WIECON-ECE)
92. A novel linker-immunodominant site (LIS) vaccine targeting the SARS-CoV-2 spike protein protects against severe COVID-19 in Syrian hamsters
    Bao-Zhong Zhang, Xiaolei Wang, Shuo-Feng Yuan, Wenjun Li, Y. Dou, V. Poon, C. Chan, Jian-Piao Cai, K. Chik, K. Tang et al. · 2021 · Emerging Microbes and Infections
93. RNA Vaccines against Infectious Diseases: Vital Progress with Room for Improvement
    Hana M. Abdelzaher, Asmaa S. Gabr, Basma M. Saleh, Rana M. Abdel Gawad, Ahmed A. Nour, Anwar Abdelnaser · 2021 · Vaccines
94. Engineered internal architecture of core-shell lipid nanoparticles promotes efficient mRNA endosomal release
    Tianyao Li, Jingxin Zhang, Jing Guo et al. · 2026 · Nature Communications
95. Engineered mRNAs With Stable Structures Minimize Double-stranded RNA Formation and Increase Protein Expression
    Qianshan Qin, Huayuan Yan, Weixiang Gao, Ruyin Cao, Guopeng Liu, Xiaojing Zhang, Niangang Wang, Wenjie Zuo, Lei Yuan, Peng Gao et al. · 2024 · Journal of Molecular Biology
96. Multiple tail ionizable lipids improve in vivo mRNA delivery efficiency with biosafety
    Chao Liu, Yuhao Jiang, Wenliang Xue, Jinyu Liu, Zihao Wang, Xinsong Li · 2024 · International Journal of Pharmaceutics
97. Harnessing the Biological Responses Induced by Nanomaterials for Enhanced Cancer Therapy
    Liting Wang, Hao Fu, Jiangtao Lin, Meng Liang Zhao, Chuanrong Chen, Hongze Liao, Yourong Duan · 2025 · Aggregate
98. Animal models for studying coronavirus infections and developing antiviral agents and vaccines
    Qisheng Lin, Chunni Lu, Yuqi Hong, Runfeng Li, Jinding Chen, Weisan Chen, Jianxin Chen · 2022 · Antiviral Research
99. Towards novel nano-based vaccine platforms for SARS-CoV-2 and its variants of concern: Advances, challenges and limitations
    Sally A. Helmy, Rasha M. EL Morsi, Soha M. El-Masry, Soha M. El-Masry · 2022 · Journal of Drug Delivery Science and Technology
100. High-throughput screening of spike variants uncovers the key residues that alter the affinity and antigenicity of SARS-CoV-2
     Yufeng Luo, Shuo Liu, Jiguo Xue, Ye Yang, Junxuan Zhao, Ying Sun, Bolun Wang, Shenyi Yin, Juan Li, Yuchao Xia et al. · 2023 · Cell Discovery